By Du Xiaoli (chinadaily.com.cn), 8 Oct 2006
Domestic vaccine enterprises showed obvious advantages in China's flu vaccine market compared with their foreign counterparts this year, breaking the foreign enterprise monopoly of flu vaccines for the first time, according to the Beijing Business Today.
It is reported that 25 million doses of the flu vaccines will be put on the Chinese market this year, the largest supply in history. Domestically produced vaccines grasped two thirds of the market share and domestic pharmaceutical enterprises became the biggest winner on China's flu vaccine market this year.
"The development of global vaccine giants is restricted to a certain extent on China's market," said a person surnamed Fan from Jiangsu Yanshen Biological Technology Stock Co Ltd.
The full text is available in the Sept-Oct Issue of China Medicine.